Synopsis Data regarding the clinical outcome and mechanism of arrhythmia recurrence following persistent Atrial Fibrillation (AF) ablation using Cryoballoon (CB) is sparse. The present study was aimed to assess the efficacy of CB and mechanisms of atrial tachyarrhythmia (ATA) recurrence in patients with persistent AF. This week’s “MED FACT” discusses a clinical trial from Clinical Research in Cardiology, “Safety and efficacy of persistent atrial fibrillation ablation using the second-generation cryoballoon”.
Authors: Kivanc Yalin, Amr Abdin, Evgeny Lyan, Noureddin Sawan, Spyridon Liosis, Christian Elsner, Alexander Jobs, Ben Brüggemann, Jelena Koester, Ingo Eitel, Charlotte Eitel, Roland Richard Tilz Key Takeaways Second-generation cryoballoon use is associated with an excellent safety profile and favorable outcomes In patients with persistent AF. Objective: To assess the efficacy of CB…
